Analysis for Iterum Therapeutics
Description & usage
Iterum Therapeutics is a biopharma company focused on anti-infective therapies. The business is highly dependent on regulatory outcomes and clinical execution. Key drivers are approval milestones, clinical data, funding runway, and commercialization progress.
Basic info
- Symbol
- ITRM
- Type
- Stock
- Region
- Europe
- Sector
- Industrials
- Available history
- 7.9 years
- Last trading day
- 04/02/2026
Basic info
- Symbol
- ITRM
- Type
- Stock
- Region
- Europe
- Sector
- Industrials
- Available history
- 7.9 years
- Last trading day
- 04/02/2026
Market context
- DXY
- 120.89
- US 10Y Real
- 1.99%
- Fed Balance
- $6.68T
- EZ HICP
- 2.0%
- ECB Rate
- 4.25%
- Bund 10Y
- 3.03%
- VIX
- 24.54
- HY OAS
- 3.17%
- Brent
- $121.88
- Core HICP
- 2.3%
- DE 2Y
- 2.62%
- EZ PMI
- –
Score overview
The overall score combines Performance, Stability and Trend into one comparable value.
Market context
- DXY
- 120.89
- US 10Y Real
- 1.99%
- Fed Balance
- $6.68T
- EZ HICP
- 2.0%
- ECB Rate
- 4.25%
- Bund 10Y
- 3.03%
- VIX
- 24.54
- HY OAS
- 3.17%
- Brent
- $121.88
- Core HICP
- 2.3%
- DE 2Y
- 2.62%
- EZ PMI
- –
Analysis summary
Technical asset picture
Iterum Therapeutics (ITRM) currently has a total score of 7 points, placing it in the very weak range. The score is made up of Performance (1), Stability (10) and Trend (18). All three sub-scores are currently below average.
Performance scores 1 points (very weak). Least weak metric: 3Y return at -68.1 %. Main drag: 5Y return at -98.6 %.
Stability scores 10 points (very weak). Least weak metric: Sharpe ratio (90d) at -0.33. Main drag: current drawdown at -99.9 %. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns-but prices can still fall.
Trend scores 18 points (very weak). Trend signals are mostly negative right now. Least weak signal: Price is about 3.0 % below SMA50. Main drag: Price is about 47.1 % below SMA200.
Overall, the picture is very weak: none of the three dimensions shows a clear strength. On a metric level, SMA50 distance stands out, while 5Y return lags.
Current market backdrop
The backdrop currently looks mixed and rather restrictive.
A strong US dollar currently paints a mixed risk picture.
High US real yields and elevated long yields lean toward a restrictive rate backdrop.
What that typically means here
For this asset type, the current backdrop looks mixed rather than clearly directional.
Note: Euro area PMI was not used actively in the effect logic.
Historical evaluation and qualitative market context only, not investment advice.
Price chart
Use the chart to read recent price behavior before drilling into metrics.
Scores and metrics
Explore the overall score, the three pillar scores, and the metrics behind them.